Skip to main content
. 2009 Nov 30:345–374. doi: 10.1016/B978-141600119-5.50016-0

TABLE 13-2.

Dosages for Common Injectable Sedatives, Analgesics, Preanesthetics, Anesthetics, and Antagonists Used in Ferrets

Drug Dosage Use
Acepromazine 0.2-0.5 mg/kg SC, IM sedative
0.1-0.25 mg/kg SC, IM preanesthetic
Atipamizole 0.4 mg/kg IM alpha-2 antagonist
Buprenorphine 0.01 mg/kg SC, IM analgesia
Butorphanol 0.05-0.1 mg/kg SC, IM analgesia
Diazepam 1-2 mg/kg IM sedative
Ketamine 10-20 mg/kg IM sedative
30-60 mg/kg IM anesthetic
Ketamine/diazepam 25-35 mg/kg (K), 2-3 mg/kg (D) IM anesthetic
Ketamine/medetomidine 5 mg/kg (K), 0.08 mg/kg (M) IM anesthetic
Ketamine/medetomidine/butorphanol 5 mg/kg (K), 0.08 mg (M), 0.1 mg/kg (B) IM anesthetic
Ketamine/xylazine 20-40 mg/kg (K), 1-4 mg/kg (X) IM anesthetic
Medetomidine 0.08-0.1 mg/kg IM sedative
Medetomidine/butorphanol 0.08 mg/kg (M), 0.1 mg/kg (B) IM anesthetic
Naloxane 0.04-1.0 mg/kg IV, IM, SC opioid antagonist
Telazol 12-22 mg/kg IM anesthetic at higher dosage
Xylazine 1 mg/kg SC, IM sedative
Yohimbine 0.5 mg/kg IM alpha-2 antagonist

Dosages acquired from Marini RP, Fox JG: Anesthesia, surgery, and biomethodology. In Fox JG, editor: Biology and Diseases of the Ferret, ed 2, Philadelphia, 1998, Lippincott Williams and Wilkins.

© 2009 Lippincott Williams and Wilkins

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.